PHARMACEUTICAL PREPARATIONS TREATING CANCER

Brand Owner (click to sort) Address Description
ACCENT Accent Therapeutics, Inc. 65 Hayden Avenue Lexington MA 02421 Pharmaceutical preparations for treating cancer;
ACCENT Accent Therapeutics, Inc. 65 Hayden Avenue Lexington MA 02421 Pharmaceutical preparations for treating cancer;Research and development of pharmaceutical preparations;
ANAVEON Anaveon AG Hochbergerstrasse 60C CH-4057 Basel Switzerland Pharmaceutical preparations for treating cancer or autoimmune diseases;Advertising;Research and development in the pharmaceutical and biotechnology fields; industrial research in the field of pharmaceuticals; research and development services in the field of immunology; research and development for the pharmaceutical industry; scientific research services for medical purposes; scientific research for medical purposes in the field of cancerous diseases; scientific research, testing and analysis services; scientific and medical research and development; provision of information relating to medical and scientific research in the field of pharmaceutical products; laboratory research and analysis services;
ANAVEON Anaveon AG Hochbergerstrasse 60C CH-4057 Basel Switzerland Pharmaceutical preparations for treating cancer or autoimmune diseases;Advertising;Research and development in the pharmaceutical and biotechnology fields; industrial research in the field of pharmaceuticals; research and development services in the field of immunology; research and development for the pharmaceutical industry; scientific research services for medical purposes; scientific research for medical purposes in the field of cancerous diseases; scientific research, testing and analysis services; scientific and medical research and development; provision of information relating to medical and scientific research in the field of pharmaceutical products; laboratory research and analysis services;
ANGIOTX HELOMICS CORPORATION Suite 110 91 43rd Street Pittsburgh PA 15201 pharmaceutical preparations for treating cancer, infectious disease, and cardiovascular conditions;
AYVAKIT Blueprint Medicines Corporation 45 Sidney Street Cambridge MA 02139 Pharmaceutical preparations for treating cancer and mastocytosis;
AYVAKITVA Blueprint Medicines Corporation 45 Sidney Street Cambridge MA 02139 Pharmaceutical preparations for treating cancer and mastocytosis;
CACHEXINOL Another Chance Nutra 6598 Buttercup Drive, Unit 4 Wellington CO 80549 Pharmaceutical preparations for treating cancer and cachexia; dietary and nutritional supplements;
CANTRIXIL Kazia Therapeutics Limited Three International Towers, Australia Pharmaceutical preparations for treating cancer; anti-cancer pharmaceutical preparations; pharmaceutical preparations for the diagnosis and treatment of cancer; medicines for treating cancer for human use; pharmaceutical products for treating cancer; pharmaceutical compounds for treating cancer; chemical preparations for pharmaceutical purposes, namely, for treating cancer; chemical preparations for treating cancer; diagnostic preparations for medical purposes;
CELLFX HELOMICS CORPORATION Suite 110 91 43rd Street Pittsburgh PA 15201 pharmaceutical preparations for treating cancer, infectious diseases, and cardiovascular conditions;CELL EFFECTS;CELL FX;
CHEMOTX HELOMICS CORPORATION Suite 110 91 43rd Street Pittsburgh PA 15201 pharmaceutical preparations for treating cancer, infectious disease, and cardiovascular conditions;
CYDENITOR Otsuka Pharmaceutical Co., Ltd. 2-9 Kanda-Tsukasamachi, Chiyoda-ku Tokyo 101-8535 Japan Pharmaceutical preparations for treating cancer; pharmaceutical preparations for treating immune disorders; pharmaceutical preparations for treating hematological disorders;
EPITARGET Epitarget AS Oscars gate 27 0352 Oslo Norway pharmaceutical preparations for treating cancer, infections, inflammations, heart or cardiovascular disease, neurological disease, skin conditions and skin disease and diabetes; sanitary preparations for medical purposes; dietary supplements for medical use;medical services;scientific research services for medical purposes;
EXO-TARGET ILIAS BIOLOGICS INC. 40-20 Techno 6-ro, Yuseong-gu Daejeon 34014 Republic of Korea Pharmaceutical preparations for treating cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemico-pharmaceutical preparations for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; drug delivery agents for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biological preparations comprising extracellular vesicles known as exosomes for therapeutic applications; extracellular vesicles for pharmaceutical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biochemicial drug for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemical preparations for pharmaceutical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemical preparations for medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; preparations of microorganisms for medical and veterinary use for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; reagents for use in medical genetic testing; diagnostic reagents for medical use; biological preparations for medical or veterinary purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biological reagents for clinical medical use;Biological preparations, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; biological preparation for use in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of cosmetics; protein for use in the manufacture of cosmetics; proteins for the food industry; chemical reagents, other than for medical or veterinary purpose;Biotechnology research; technological research in the field of cell biology; laboratory research in the field of cell biology; pharmaceutical drug development services; genetic testing for scientific research purposes; research in the field of chemistry; drug discovery services; medical research and development services; pharmaceutical research and development services; biopharmaceutical research and development services;
GENEEX HELOMICS CORPORATION Suite 110 91 43rd Street Pittsburgh PA 15201 pharmaceutical preparations for treating cancer, infectious disease, and cardiovascular conditions;GENE EX;
GENESQ HELOMICS CORPORATION Suite 110 91 43rd Street Pittsburgh PA 15201 pharmaceutical preparations for treating cancer, infectious disease, and cardiovascular conditions;GENES Q;GENE SQ;
HELOMICS HELOMICS, INC. 91 43RD STREET PITTSBURGH PA 15201 pharmaceutical preparations for treating cancer, infectious disease, and cardiovascular conditions;
INQOVI Otsuka Pharmaceutical Co., Ltd. 2-9 Kanda-Tsukasamachi, Chiyoda-ku Tokyo 101-8535 Japan Pharmaceutical preparations for treating cancer; pharmaceutical preparations for treating immune disorders; pharmaceutical preparations for treating hematological disorders;
INSTILADRIN FERRING B.V. Polaris Avenue 144 Hoofddorp 2132JX Netherlands Pharmaceutical preparations for treating cancer and bladder diseases; veterinary preparations for cancer in dogs, bladder diseases in horses; veterinary preparations, namely, antioxidants; gene-based pharmaceuticals for the treatment of cancer and bladder diseases; pharmaceutical preparations for use in gene therapy; pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of bladder diseases; sanitary preparations for medical purposes; dietary preparations for medical purposes, namely, dietary food supplements and dietary supplements; disinfectants for hygienic purposes; disinfectants for sanitary purposes;
INSTILADRIN FKD Therapies Oy Patents & Intellectual Properties Microkatu 1S Kuopio FIN-70210 Finland Pharmaceutical preparations for treating cancer and bladder diseases; veterinary preparations for cancer in dogs, bladder diseases in horses; veterinary preparations, namely, antioxidants; gene-based pharmaceuticals for the treatment of cancer and bladder diseases; pharmaceutical preparations for use in gene therapy; pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of bladder diseases; sanitary preparations for medical purposes; dietary preparations for medical purposes, namely, dietary food supplements and dietary supplements; disinfectants for hygienic purposes; disinfectants for sanitary purposes;
INSTILADRIN Oliver Groote Billwiese 22 21033 Hamburg Germany Pharmaceutical preparations for treating cancer and bladder diseases; veterinary preparations for cancer in dogs, bladder diseases in horses; veterinary preparations, namely, antioxidants; gene-based pharmaceuticals for the treatment of cancer and bladder diseases; pharmaceutical preparations for use in gene therapy; pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of bladder diseases; sanitary preparations for medical purposes; dietary preparations for medical purposes, namely, dietary food supplements and dietary supplements; disinfectants for hygienic purposes; disinfectants for sanitary purposes;
INVENTING NEW HOPE Teon Therapeutics, Inc. 555 Twin Dolphin Drive, Suite 120 Redwood City CA 94065 Pharmaceutical preparations for treating cancer; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, circulatory, gastroenterological, digestive, hormonal, rheumatic, immune system, and metabolic diseases and disorders; pharmaceutical preparations for use in immunology, oncology including immuno-oncology, cardiovascular and metabolic diseases, pharmaceuticals designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases including transplantation and delayed-type hypersensitivity, gastrointestinal diseases, cardiovascular and metabolic diseases, and dermatologic diseases, genitourinary diseases, and orphan diseases; protein therapeutics, namely, pharmaceutical preparations for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, dermatology, urology, gynecology, hepatology; protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer and autoimmune disorders, cytokines, interferons, tumor cell targeting and cytolytic agents, tolerogenic and antiallergic factors, growth and differentiation factors, hormones, replacement enzymes, lipid binding proteins, protein factors for manufacturing of adoptive cell therapy products, and tissue repair factors; non-natural protein modifications for use in connection with a variety of therapeutic areas, namely, protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, synthetic proteins for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, dermatology, urology, gynecology, hepatology;Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of treating cancer; medical research for use in oncology; pharmaceutical research for treating neuroendocrine tumors; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, circulatory, gastroenterological, digestive, hormonal, rheumatic, immune system, and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; pharmaceutical research in the field of protein therapeutics; pharmaceutical research in the fields of immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology, hepatology, laboratory medicine, clinical diagnostics, genetics and phenomics, pathology and forensics, proteomics, veterinary medicine and diagnostics, and basic research tools; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using a semi-synthetic organism for use in drug development; pharmaceutical research, namely, research relating to synthetic proteins incorporating one or more non-natural amino acids for improving pharmacological properties; pharmaceutical research, namely, research relating to synthetic proteins for use in connection with a wide variety of therapeutic agents;
JAVNIRYS Blueprint Medicines Corporation 45 Sidney Street Cambridge MA 02139 Pharmaceutical preparations for treating cancer and mastocytosis;
JAYKITVA Blueprint Medicines Corporation 45 Sidney Street Cambridge MA 02139 Pharmaceutical preparations for treating cancer and mastocytosis;
MANAMATCH Mana Therapeutics, Inc. 5606 Albia Rd. Bethesda MD 20816 Pharmaceutical preparations for treating cancer that assist in evaluating and matching common Human Leukocyte Antigen (HLA) with antigen reactivity to potential cancer patients by using predetermined parameters to optimize efficacy and safety;MANA MATCH;Development of methodologies in the field of medicine to optimize a match between cell product and patient, matching common Human Leukocyte Antigen (HLA) with antigen reactivity to potential cancer patients in order to enhance the efficacy of Human Leukocyte Antigen (HLA) and specific antigen;
MEDASPAR medac Gesellschaft für klinische; Spezialpräparate mbH Theaterstrasse 6 22880 Wedel Germany Pharmaceutical preparations for treating cancer and autoimmune diseases;The wording MEDASPAR has no meaning in a foreign language.;
METOJECT medac Gesellschaft für klinische Spezialpräparate mbH Theaterstrasse 6 Wedel 22880 Germany Pharmaceutical preparations for treating cancer and autoimmune diseases;
MYLOTARG WYETH 235 East 42nd Street New York NY 10017 Pharmaceutical preparations for treating cancer;
O4CP Mr Vincent GREK de nationalité belge 35bis rue Henri Barbusse F-75005 PARIS France Pharmaceutical preparations for treating cancer and infectious diseases, namely, respiratory infections, eye infections, topical infections, illnesses of the immune system, namely, autoimmune diseases, immunodeficiency syndromes, diseases of the cardiovascular system, diseases of the respiratory system, diseases of the digestive system, diseases of the nervous system, psychiatric disorders, skin disorders and subcutaneous tissue disorders, renal and urinary disorders; hygienic medical goods, namely, sanitary towels; dietetic supplements, adapted for medical use, used as vitamin supplements and energy supplements for children; food for babies; all purpose disinfectants; fungicides, herbicides; medicated bath preparations; plant extracts for medical purposes, namely, for treating cancer and infectious diseases, namely, respiratory infections, eye infections, topical infections, illnesses of the immune system, namely, autoimmune diseases, immunodeficiency syndromes, diseases of the cardiovascular system, diseases of the respiratory system, illnesses of the digestive system, diseases of the nervous system, psychiatric disorders, skin disorders and subcutaneous tissue disorders, renal and urinary disorders; herbal teas for medicinal purposes; parasiticides; dietetic sugar for medical purposes;O FOUR CP; ONLY FOUR CHILDREN PHARMACEUTICALS; ONLY FOR CHILDREN PHARMACEUTICALS;Medical apparatus, namely, apparatus allowing the preparation of fresh enteral food for neonates and children and apparatus allowing precise intravenous administration of fluid and medicines to neonates, babies and children; apparatus, namely, pen devices and pump allowing the precise sub-cutaneous administration of fluid and medicines to neonates, babies and children; medical diagnostic instruments, namely, endoscope for gastro-intestinal, cardio-vascular and otho-rhyno-laryngological diseases, surgical instruments specifically adapted to the size of babies and children for gastro-intestinal, cardio-vascular and otho-rhyno-laryngological diseases, artificial limbs, eyes and teeth; orthopedic articles, namely, orthopedic soles, orthopedic corsets, orthopaedic footwear; feeding bottles; feeding bottle teats; surgical implants comprising artificial materials; armchairs for medical or dental use; bed pans for medical use; surgical knives;Research and development for new products for others;
PARPTX HELOMICS CORPORATION Suite 110 91 43rd Street Pittsburgh PA 15201 pharmaceutical preparations for treating cancer, infectious disease, and cardiovascular conditions;
PROTEINEX HELOMICS CORPORATION Suite 110 91 43rd Street Pittsburgh PA 15201 pharmaceutical preparations for treating cancer, infectious disease, and cardiovascular conditions;
PROTEINSQ HELOMICS CORPORATION Suite 110 91 43rd Street Pittsburgh PA 15201 pharmaceutical preparations for treating cancer, infectious disease, and cardiovascular conditions;PROTEINS Q;PROTEIN SQ;
PURE-EXO ILIAS BIOLOGICS INC. 40-20 Techno 6-ro, Yuseong-gu Daejeon 34014 Republic of Korea Pharmaceutical preparations for treating cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemico-pharmaceutical preparations for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; drug delivery agents for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biological preparations comprising extracellular vesicles known as exosomes for therapeutic applications; extracellular vesicles for pharmaceutical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biochemicial drug for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemical preparations for pharmaceutical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemical preparations for medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; preparations of microorganisms for medical and veterinary use for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; reagents for use in medical genetic testing; diagnostic reagents for medical use; biological preparations for medical or veterinary purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biological reagents for clinical medical use;Biological preparations, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; biological preparation for use in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of cosmetics; protein for use in the manufacture of cosmetics; proteins for the food industry; chemical reagents, other than for medical or veterinary purpose;Biotechnology research; technological research in the field of cell biology; laboratory research in the field of cell biology; pharmaceutical drug development services; genetic testing for scientific research purposes; research in the field of chemistry; drug discovery services; medical research and development services; pharmaceutical research and development services; biopharmaceutical research and development services;
RACURA medac Gesellschaft für klinische; Spezialpräparate mbH Theaterstrasse 6 22880 Wedel Germany Pharmaceutical preparations for treating cancer and autoimmune diseases;
REDEMVI Otsuka Pharmaceutical Co., Ltd. 2-9 Kanda-Tsukasamachi, Chiyoda-ku Tokyo 101-8535 Japan Pharmaceutical preparations for treating cancer; pharmaceutical preparations for treating immune disorders; pharmaceutical preparations for treating hematological disorders;
REINVENTING HOPE Teon Therapeutics, Inc. 555 Twin Dolphin Drive, Suite 120 Redwood City CA 94065 Pharmaceutical preparations for treating cancer; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, circulatory, gastroenterological, digestive, hormonal, rheumatic, immune system, and metabolic diseases and disorders; pharmaceutical preparations for use in immunology, oncology including immuno-oncology, cardiovascular and metabolic diseases, pharmaceuticals designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases including transplantation and delayed-type hypersensitivity, gastrointestinal diseases, cardiovascular and metabolic diseases, and dermatologic diseases, genitourinary diseases, and orphan diseases; protein therapeutics, namely, pharmaceutical preparations for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, dermatology, urology, gynecology, hepatology; protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer and autoimmune disorders, cytokines, interferons, tumor cell targeting and cytolytic agents, tolerogenic and antiallergic factors, growth and differentiation factors, hormones, replacement enzymes, lipid binding proteins, protein factors for manufacturing of adoptive cell therapy products, and tissue repair factors; non-natural protein modifications for use in connection with a variety of therapeutic areas, namely, protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, synthetic proteins for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, dermatology, urology, gynecology, hepatology;Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of treating cancer; medical research for use in oncology; pharmaceutical research for treating neuroendocrine tumors; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, circulatory, gastroenterological, digestive, hormonal, rheumatic, immune system, and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; pharmaceutical research in the field of protein therapeutics; pharmaceutical research in the fields of immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology, hepatology, laboratory medicine, clinical diagnostics, genetics and phenomics, pathology and forensics, proteomics, veterinary medicine and diagnostics, and basic research tools; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using a semi-synthetic organism for use in drug development; pharmaceutical research, namely, research relating to synthetic proteins incorporating one or more non-natural amino acids for improving pharmacological properties; pharmaceutical research, namely, research relating to synthetic proteins for use in connection with a wide variety of therapeutic agents;
SPECTRILA medac Gesellschaft fur klinische Spezialpraparate mbH Theaterstr. 6 Wedel 22880 Germany Pharmaceutical preparations for treating cancer and auto-immune diseases; Medicines for treating cancer and auto-immune diseases; Chemical preparations for medical purposes, namely, chemical reagents for diagnostic purposes; Medical plasters; Surgical dressings; All purpose disinfectants;The word(s) SPECTRILA has no meaning in a foreign language.;
SPECTRILA medac Gesellschaft fur klinische Spezialpraparate mbH Theaterstr. 6 Wedel 22880 Germany Pharmaceutical preparations for treating cancer and hematological diseases;
TAYKITVA Blueprint Medicines Corporation 45 Sidney Street Cambridge MA 02139 Pharmaceutical preparations for treating cancer and mastocytosis;
TEON Teon Therapeutics, Inc. 555 Twin Dolphin Drive, Suite 120 Redwood City CA 94065 Pharmaceutical preparations for treating cancer; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceuticals for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; pharmaceutical preparations for use in immunology, oncology including immuno-oncology, cardiovascular and metabolic diseases, and infectious diseases; pharmaceuticals designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases including transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases, and orphan diseases; protein therapeutics, namely, pharmaceutical preparations for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics; protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer and autoimmune disorders, cytokines, interferons, tumor cell targeting and cytolytic agents, tolerogenic and antiallergic factors, growth and differentiation factors, hormones, replacement enzymes, coagulation factors, lipid binding proteins, protein factors for manufacturing of adoptive cell therapy products, anti-infectives, pain killers, and tissue repair factors; non-natural protein modifications for use in connection with a variety of therapeutic areas, namely, protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, synthetic proteins for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics;Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of treating cancer; medical research for use in oncology; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; pharmaceutical research in the field of protein therapeutics; pharmaceutical research in the fields of immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, geriatrics, laboratory medicine, clinical diagnostics, genetics and phenomics, pathology and forensics, proteomics, veterinary medicine and diagnostics, and basic research tools; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using a semi-synthetic organism for use in drug development; pharmaceutical research, namely, research relating to synthetic proteins incorporating one or more non-natural amino acids for improving pharmacological properties; pharmaceutical research, namely, research relating to synthetic proteins for use in connection with a wide variety of therapeutic agents;
TVARDI Tvardi Therapeutics, Inc. 3 Sugar Creek Center Boulevard Suite 525 Sugar Land TX 77478 Pharmaceutical preparations for treating cancer;
TVARDI Tvardi Therapeutics, Inc. 3 Sugar Creek Center Boulevard Suite 525 Sugar Land TX 77478 Pharmaceutical preparations for treating cancer, inflammation and fibrosis;
VIVESTO Vivesto AB Vallongatan 1 Uppsala SE-752 16 Sweden Pharmaceutical preparations for treating cancer; veterinary preparations for treating cancer; chemicals for pharmaceutical use for treating cancer;Laboratory chemicals for scientific use; chemicals for use in science;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The present invention relates to a method for treating cancer using p38/JTV-1 and a method for screening pharmaceutical composition for treating cancer. More particularly, this invention relates to the method for treating cancer, which comprises administering the effective amount of p38/JTV-1 protein or a nucleic acid encoding for said protein to the patient and the method for screening a pharmaceutical composition for treating cancer characterized by selecting a substance having an effect on the increase of the activity of the p38/JTV-1 protein and the intracellular level thereof.